soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Forecasting Milestones: A Predictive Analysis for Early Termination of the Study | Diabetes Therapy soul trial oral semaglutide cardiovascular

Some early research suggests that GLP-1 agonists like semaglutide might have cognitive benefits, including improved focus and attention

Animal studies at effective doses showed no overt toxicity, but this cannot be extrapolated to human safety

The FDA recently approved another use for semaglutide, allowing it to help patients battling chronic weight management, but quite often these medications are not covered by insurance

(source: manufacturer info) We don't have description for this ingredient yet

Importantly, Rybelsus is not FDA-approved for chronic weight management and should not be used for weight loss

News provided by Supergut Jun 17, 2025, 08:43 ET The clinically-backed formula is now available in summer flavors to support gut-health